Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • bootpart bootpart Dec 4, 2012 7:57 AM Flag

    What are the real options for vrtx?

    As the CFO said they'll essentially slash SGA expenses moving forward. It seems they are trying to live thru the next 2 years of declining rev by reducing exp with a big CF payday in 2015 and beyond. If those drugs work then they will generate rev of at least 3-4b.
    Another option is to reduce their dev exp by shutting down or selling off programs. I don't think vrtx is big enough to bring a flu drug or a RA drug to market. Both molecules look good so far but they could sell or partner with both to progress them further. Would reduce expenses a lot. Most people working these clinical programs would not be needed and would be laid off. I think the latter is a better option.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
VRTX
128.83-2.43(-1.85%)Jul 6 4:00 PMEDT